The protein C pathway in cancer metastasis.

Abstract:

:Cancer is frequently associated with activation of blood coagulation, which in turn has been suggested to promote tumor growth and metastasis. Indeed, low molecular weight heparin treatment significantly prolongs the survival of a wide variety of patients with cancer. Based on this notion that anticoagulant treatment seems to benefit cancer patients, recent experiments aimed to elucidate the importance of the natural anticoagulant protein C pathways in cancer progression. Interestingly, these experiments showed that the repeated administration of exogenous activated protein C limits cancer cell extravasation in experimental animal models. In line, reducing endogenous activated protein C activity dramatically increased the number of experimental metastasis. These data thus strongly suggest that exogenous activated protein C administration may be a novel therapeutic avenue to limit cancer metastasis thereby prolonging overall survival of cancer patients. The current review provides an overview of recent data on the role of the protein C pathway in cancer metastasis. It discusses the potential of activated protein C as a novel target to reduce cancer progression, it points to several limitations of activated protein C administration in the setting of cancer cell metastasis and it suggest zymogen protein C as an attractive alternative.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Spek CA,Arruda VR

doi

10.1016/S0049-3848(12)70022-1

subject

Has Abstract

pub_date

2012-04-01 00:00:00

pages

S80-4

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(12)70022-1

journal_volume

129 Suppl 1

pub_type

杂志文章,评审
  • The effect of sulphinpyrazone on whole blood thromboxane and prostacyclin generation in man.

    abstract::A new method, based on the observation that leukocytes contain PGI2-synthetase activity, was used to measure the effect of pharmacological levels of sulphinpyrazone on the TXA2 and PGI2 production in whole blood. Four human volunteers took 400 mg sulphinpyrazone twice daily for 5 1/2 days. Blood was drawn before the s...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90033-0

    authors: Badenhorst PN,Deckmyn H,Vermylen J

    更新日期:1982-10-01 00:00:00

  • Platelet procoagulant activity induced in vivo by muromonab-CD3 infusion in uremic patients.

    abstract:BACKGROUND:Muromonab-CD3 is a murine monoclonal antibody (MoAb) that is used in the prophylaxis and treatment of acute graft rejection. Activation of coagulation and fibrinolysis following anti-CD3 administration have been reported in some patients to lead to irreversible intragraft thrombosis. DESIGN AND METHODS:We h...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00396-6

    authors: Lozano M,Oppenheimer F,Cofan F,Rosinyol L,Mazzara R,Escolar G,Ordinas A

    更新日期:2001-12-15 00:00:00

  • Platelet activation in pregnancy-induced hypertension.

    abstract:BACKGROUND:Although excess platelet activation, as indicated by increased plasma beta thromboglobulin (beta-TG), has been shown in pregnancy-induced hypertension (PIH), platelet adhesion, platelet morphology and a comparison of platelet and soluble (plasma) levels of the adhesion molecules P-selectin (pPsel and sPsel, ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2005.01.009

    authors: Karalis I,Nadar SK,Al Yemeni E,Blann AD,Lip GY

    更新日期:2005-01-01 00:00:00

  • An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.

    abstract::When activated in vitro, thrombin-activatable fibrinolysis inhibitor (TAFI) slows clot lysis by cleaving the C-terminal lysine and arginine residues from partially degraded fibrin. An inhibitor of carboxypeptidase isolated from potato (CPI) reverses prolongation of clot lysis by inhibiting activated TAFI. We investiga...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00184-5

    authors: Nagashima M,Werner M,Wang M,Zhao L,Light DR,Pagila R,Morser J,Verhallen P

    更新日期:2000-05-15 00:00:00

  • Inhibitory effect of fibronectin on the fibrin formation.

    abstract::125I-fibronectin is incorporated into fibrin when blood plasma is clotted with thrombin. This process is dependent upon fibronectin concentration, temperature, and the presence of calcium ions. Fibronectin appears to be a very strong inhibitor of fibrin formation and influences both the thrombin clotting time and fibr...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90308-5

    authors: Niewiarowska J,Cierniewski CS

    更新日期:1982-09-01 00:00:00

  • Parallel characterization of bovine von Willebrand protein (factor VIII-associated protein) by light scattering and SDS gel electrophoresis.

    abstract::Highly purified bovine von Willebrand protein (vWP) has been studied with two complementary techniques. Light scattering measurements on different samples give weight average molecular weights in the range from 7 to 13 million, radius of gyration between 75 and 140 nm and diffusion coefficient near 4.15 X 10(-8) cm2/s...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(85)90289-0

    authors: Binnie C,Wagner RH,Cooper H,Hermans J

    更新日期:1985-11-15 00:00:00

  • Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor.

    abstract::Activated factor X (FXa) and thrombin can up-regulate gene expression of connective tissue growth factor (CTGF/CCN2) on fibroblasts. Since tissue factor (TF) is expressed on these cells, we hypothesized that they may assemble the prothrombinase complex leading to CTGF/CCN2 upregulation. In addition, the effect of thro...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2011.08.009

    authors: Rico MC,Rough JJ,Manns JM,Del Carpio-Cano F,Safadi FF,Kunapuli SP,DeLa Cadena RA

    更新日期:2012-06-01 00:00:00

  • Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations.

    abstract::In this study, we investigated the effects of a 3-min insulin incubation both at physiological and at supraphysiological concentrations on platelet aggregation and intraplatelet cyclic guanosine monophosphate (cGMP) levels both in the absence and in the presence of phosphodiesterase inhibition. We observed that insuli...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(96)00051-5

    authors: Anfossi G,Massucco P,Mattiello L,Piretto V,Mularoni E,Cavalot F,Paoletti G,Trovati M

    更新日期:1996-04-01 00:00:00

  • EUHASS: The European Haemophilia Safety Surveillance system.

    abstract::Pharmacovigilance is an essential element of any drug treatment and considering the history of adverse events due to products used to treat inherited bleeding disorders, it should be an integral component of modern haemophilia treatment. Because inherited bleeding disorders and adverse events are rare, a multicentre, ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/S0049-3848(10)70150-X

    authors: Makris M,Calizzani G,Fischer K,Gilman EA,Hay CR,Lassila R,Lambert T,Ludlam CA,Mannucci PM

    更新日期:2011-01-01 00:00:00

  • Allele frequencies of two polymorphisms associated with the factor IX gene in Iranian population.

    abstract::Indirect genetic diagnosis using polymorphic DNA markers can be useful in large-scale screening programs, which is technically simpler, more rapid and amenable. The main objective of this study was to test the informativeness of two common intragenic markers (TaqI and XmnI) in Iranian haemophilia B families to detect ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.03.009

    authors: Ghandil P,Ghadiri A,Farhud D,Zeinali S

    更新日期:2004-01-01 00:00:00

  • Plasminogen and tissue plasminogen activator interact with antithrombin III.

    abstract::Human antithrombin III was demonstrated to bind plasminogen specifically in a time and concentration-dependent manner. The above binding was also confirmed using ligand western blot assays. The interaction of plasminogen was significantly (>90%) inhibited by lysine, indicating the involvement of kringles in binding an...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00268-1

    authors: Dudani AK

    更新日期:2000-09-15 00:00:00

  • Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.

    abstract::Four calcium channel blockers (nimodipine, nifedipine, verapamil and diltiazem) of three chemical classes were tested in vitro for inhibition of platelet aggregation using heparinized human platelet rich plasma. Both ADP- and thrombin-induced aggregation were inhibited as was the biosynthesis of thromboxane A2 in resp...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90241-x

    authors: Onoda JM,Sloane BF,Honn KV

    更新日期:1984-06-01 00:00:00

  • Increased in vitro platelet aggregation in hypertriglyceridemias.

    abstract::Platelet aggregation induced by ADP and collagen was monitored in 25 patients with increased serum levels of triglycerides (7 HLPs type IIb, 14 type IV, 4 type V patients) and compared with a group of 10 normolipidaemic control persons. Platelet aggregation was studied simultaneously in platelet rich plasma (PRP) by b...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90238-0

    authors: Riess H,Merk W,Falkner C,Hiller E

    更新日期:1986-02-01 00:00:00

  • Assessment for evidence of non A-non B hepatitis in patients given n-heptane-suspended heat-treated clotting factor concentrates.

    abstract::Nineteen patients, (2 adults, 17 children) with inherited bleeding disorders were infused with n-heptane-suspended-heated clotting factor concentrates. Twelve of the nineteen were previously untreated. Six patients were infused with Profilnine Heat-Treated and 13 with Profilate Heat-Treated. Five separate centers part...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90074-0

    authors: Carnelli V,Gomperts ED,Friedman A,Aledort L,Hilgartner M,Dietrich S,Fedor EJ

    更新日期:1987-06-15 00:00:00

  • Two novel anti-von Willebrand factor monoclonal antibodies.

    abstract::Von Willebrand Factor is a multimer produced by endothelial cells and megakaryocytes, being stored in intracellular organelles, such as the Weibel-Palade bodies and alpha-granules in endothelial cells and platelets, respectively. This molecule acts as a carrier protein for factor VIIIc, involved in the intrinsic pathw...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00122-x

    authors: Spadafora-Ferreira M,Lopes AA,Coelho V,Guilherme L,Kalil J

    更新日期:2000-01-15 00:00:00

  • Non-activated plasma-derived PC improves amputation rate of children undergoing sepsis.

    abstract::Low circulating protein C (PC) levels have been observed in sepsis, especially in patients with Neisseriae Meningitides infections. Poor clinical outcome and high limb amputation rates have been associated in infected patients with low circulating PC levels. Published studies using activated PC replacement therapy pat...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.04.019

    authors: Piccin A,O' Marcaigh A,Mc Mahon C,Murphy C,Okafor I,Marcheselli L,Casey W,Claffey L,Smith OP

    更新日期:2014-07-01 00:00:00

  • Beyond cell based models of coagulation: analyses of coagulation with clot "lifespan" resistance-time relationships.

    abstract::Cell based models of coagulation (CBM) have provided mechanistic insight into numerous hematological issues for nearly two decades. This review discusses another coagulation model system--the clot lifespan model (CLSM)--that has been designed to compliment the CBM-based approach to elucidating the mechanisms responsib...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2007.09.003

    authors: Nielsen VG

    更新日期:2008-01-01 00:00:00

  • Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis.

    abstract:BACKGROUND:Cerebral vein thrombosis (CVT) is a rare, life-threatening disease affecting one adult per 100,000 per year. Genetic risk factors are deficiencies of the natural anticoagulant proteins antithrombin, protein C, protein S or single nucleotide polymorphisms such as factor V Leiden and prothrombin 20210A. In 20%...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.06.011

    authors: Gorski MM,de Haan HG,Mancini I,Lotta LA,Bucciarelli P,Passamonti SM,Cairo A,Pappalardo E,van Hylckama Vlieg A,Martinelli I,Rosendaal FR,Peyvandi F

    更新日期:2018-09-01 00:00:00

  • Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism.

    abstract:BACKGROUND:Systemic thrombolysis rapidly improves right ventricular (RV) dysfunction in patients with acute pulmonary embolism (PE) but is associated with major bleeding complications in up to 20%. The efficacy of low-dose, catheter-directed ultrasound-accelerated thrombolysis (USAT) on the reversal of RV dysfunction i...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2011.05.014

    authors: Engelhardt TC,Taylor AJ,Simprini LA,Kucher N

    更新日期:2011-08-01 00:00:00

  • A new variant of von Willebrand disease (type II I) with a normal degree of proteolytic cleavage of von Willebrand factor.

    abstract::A variant of type II von Willebrand disease (vWd) is described in a young woman and her mother with severe lifelong bleeding histories. On electrophoresis with low-resolution agarose gels the plasma of the proband lacked large and intermediate-size multimers of von Willebrand factor (vWF) but the platelet multimeric s...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90165-7

    authors: Castaman G,Rodeghiero F,Lattuada A,Mannucci PM

    更新日期:1992-02-01 00:00:00

  • Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.

    abstract::Heparin cofactor II (HCII) is a specific thrombin inhibitor; its inhibitory activity is stimulated by heparin (Hep) and dermatan sulfate (DS). Vitronectin (VN), a heparin binding adhesive glycoprotein present in plasma and extracellular matrix, has been shown to decrease the stimulatory effect of Hep but not of DS on ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90310-7

    authors: Petzelbauer E,Seiffert D,Beckmann R,Pusch B,Geiger M,Binder BR

    更新日期:1992-06-01 00:00:00

  • Endogenous forms of fibrinogen in Hep G2 cells.

    abstract::The three polypeptide chains of fibrinogen, A alpha, B beta and gamma chain, are synthesized on separate polysomes. Fully formed fibrinogen is a six chain, disulfide-linked, dimeric molecule with a molecular weight of 340kDa. Previous pulse-chase studies with L-35 S methionine using the human hepatocellular carcinoma ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90290-8

    authors: Yu S,Kong V,Kudryk B,Redman C

    更新日期:1987-04-15 00:00:00

  • Properties and catabolism of heat treated antithrombin III concentrate.

    abstract::Heat treatment is employed to diminish the transmission of hepatitis when blood products are administered. It is possible that such a procedure could reduce the biological activity of the proteins and induce changes in structure and aggregation state. We have therefore made in vitro and pharmacokinetic studies of heat...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90435-x

    authors: Tengborn L,Frohm B,Nilsson LE,Johansson L,Andersson LO

    更新日期:1987-12-15 00:00:00

  • Reversible acylation of factor Xa as a potential therapy for hemophilia.

    abstract::Current therapies for treatment of hemophilia A involve infusion of factor VIII, but are ineffective for patients who develop inhibitory antibodies. We have previously proposed that bypassing the intrinsic pathway (VIIIa/IXa) with reversibly acylated factor Xa offers an improvement on existing therapies as it provides...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(97)00267-3

    authors: Lin PH,Laibelman AM,Sinha U

    更新日期:1997-11-15 00:00:00

  • Pressure influences the rate of fibrin polymerization: decompression accelerates, compression decelerates.

    abstract::We report here that the rate of fibrin polymerization is accelerated by decompression: the rate is essentially doubled by reducing the pressure by one-half (380 torr, 14.7 PSI or 1/2 ATM) and increased by 3.6 times with respect to the control at 25 torr (0.48 PSI or 1/30th ATM). We also report here that the rate of fi...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(88)90251-4

    authors: Murayama M

    更新日期:1988-03-15 00:00:00

  • Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.

    abstract:OBJECTIVES:To measure the variations of different parameters in the hemostatic system and to analyze their roles in the development of hemostatic disorder in patients with orthotopic liver transplantation (OLT) procedures routinely performed without venovenous bypass. METHODS:The blood coagulation and fibrinolysis par...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2007.10.002

    authors: Wang Y,Liu Y,Han R,Zhu Z,Zhang Y,Wang X,Wang L,Shen Z

    更新日期:2008-01-01 00:00:00

  • Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis.

    abstract:INTRODUCTION:Tissue factor plays a key role in the extrinsic coagulation pathway and is induced by inflammatory cytokines. Atrial myocarditis has been detected recently in some patients with lone atrial fibrillation. Virchow's triad of low blood flow, hypercoagulability, and endothelial dysfunction, enhances thrombus f...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(03)00405-5

    authors: Nakamura Y,Nakamura K,Fukushima-Kusano K,Ohta K,Matsubara H,Hamuro T,Yutani C,Ohe T

    更新日期:2003-01-01 00:00:00

  • Variables influencing the clot lysis assay of streptokinase.

    abstract::Clot lysis induced by streptokinase has been studied and the influences of pH and the concentrations of plasminogen, fibrinogen and buffer composition investigated. Variations in the concentrations of plasminogen strongly effect the SK apparent activity, maxima being obtained at different plasminogen concentrations li...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(91)90071-4

    authors: Westlund LE,Andersson LO

    更新日期:1991-12-15 00:00:00

  • Heparanase procoagulant effects and inhibition by heparins.

    abstract::Heparanase is an endo-beta-D-glucuronidase capable of cleaving heparan sulfate (HS) side chains of heparan sulfate proteoglycans (HSPG) on cell surfaces and the extracellular matrix, activity that is strongly implicated in tumor metastasis and angiogenesis. Evidence was provided that heparanase over-expression in canc...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/S0049-3848(10)70018-9

    authors: Nadir Y,Brenner B

    更新日期:2010-04-01 00:00:00

  • Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.

    abstract::Anticoagulant properties of three sulfated compounds prepared from xylans isolated from corn cobs, larchwood and oatspelts were compared with heparin and sodium pentosan polysulfate (SP-54) by studying their effects on activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT) using poo...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90148-4

    authors: Campbell A,Nesheim ME,Doctor VM

    更新日期:1987-08-01 00:00:00